Clearstead Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $59.5M | Sell |
234,177
-27,959
| -11% | -$6.52M | 0.56% | 41 |
|
|
2026
Q1 | $64.1M | Buy |
262,136
+26,626
| +11% | +$6.2M | 0.59% | 38 |
|
|
2025
Q4 | $48.7M | Sell |
235,510
-610
| -0.3% | -$121K | 0.61% | 37 |
|
|
2025
Q3 | $43.8M | Sell |
236,120
-2,518
| -1% | -$431K | 0.57% | 38 |
|
|
2025
Q2 | $36.5M | Sell |
238,638
-2,511
| -1% | -$386K | 0.51% | 46 |
|
|
2025
Q1 | $40M | Buy |
241,149
+15,258
| +7% | +$2.39M | 0.62% | 34 |
|
|
2024
Q4 | $32.7M | Sell |
225,891
-12,623
| -5% | -$1.96M | 0.5% | 46 |
|
|
2024
Q3 | $38.7M | Sell |
238,514
-647
| -0.3% | -$103K | 0.6% | 36 |
|
|
2024
Q2 | $35M | Buy |
239,161
+157,566
| +193% | +$23.4M | 0.6% | 37 |
|
|
2024
Q1 | $12.3M | Sell |
81,595
-2,050
| -2% | -$326K | 0.61% | 34 |
|
|
2023
Q4 | $13.1M | Sell |
83,645
-96,809
| -54% | -$14.8M | 0.7% | 30 |
|
|
2023
Q3 | $28.1M | Buy |
180,454
+99,805
| +124% | +$16.5M | 0.82% | 28 |
|
|
2023
Q2 | $13.3M | Buy |
80,649
+19,032
| +31% | +$3.07M | 0.81% | 26 |
|
|
2023
Q1 | $9.55M | Buy |
61,617
+1,427
| +2% | +$230K | 0.7% | 30 |
|
|
2022
Q4 | $10.6M | Buy |
60,190
+962
| +2% | +$166K | 0.83% | 25 |
|
|
2022
Q3 | $9.68M | Sell |
59,228
-10,213
| -15% | -$1.73M | 0.89% | 22 |
|
|
2022
Q2 | $12.3M | Buy |
69,441
+1,633
| +2% | +$291K | 0.96% | 20 |
|
|
2022
Q1 | $12M | Buy |
67,808
+2,207
| +3% | +$376K | 0.82% | 25 |
|
|
2021
Q4 | $11.2M | Buy |
65,601
+2,807
| +4% | +$460K | 0.76% | 28 |
|
|
2021
Q3 | $10.1M | Sell |
62,794
-697
| -1% | -$119K | 0.76% | 27 |
|
|
2021
Q2 | $10.5M | Buy |
63,491
+3,382
| +6% | +$560K | 0.8% | 23 |
|
|
2021
Q1 | $9.88M | Buy |
60,109
+2,815
| +5% | +$455K | 0.82% | 25 |
|
|
2020
Q4 | $9.02M | Buy |
57,294
+9,162
| +19% | +$1.35M | 0.82% | 24 |
|
|
2020
Q3 | $7.17M | Sell |
48,132
-751
| -2% | -$111K | 0.77% | 29 |
|
|
2020
Q2 | $6.87M | Buy |
48,883
+847
| +2% | +$123K | 0.79% | 29 |
|
|
2020
Q1 | $6.3M | Sell |
48,036
-1,854
| -4% | -$263K | 0.92% | 20 |
|
|
2019
Q4 | $7.28M | Buy |
49,890
+875
| +2% | +$119K | 0.88% | 21 |
|
|
2019
Q3 | $6.34M | Sell |
49,015
-867
| -2% | -$114K | 0.85% | 25 |
|
|
2019
Q2 | $6.95M | Buy |
49,882
+1,525
| +3% | +$211K | 0.93% | 21 |
|
|
2019
Q1 | $6.76M | Buy |
48,357
+1,253
| +3% | +$168K | 0.93% | 19 |
|
|
2018
Q4 | $6.08M | Buy |
47,104
+5,044
| +12% | +$704K | 0.95% | 20 |
|
|
2018
Q3 | $5.81M | Buy |
42,060
+862
| +2% | +$115K | 0.8% | 24 |
|
|
2018
Q2 | $5M | Buy |
41,198
+633
| +2% | +$79K | 0.71% | 28 |
|
|
2018
Q1 | $5.2M | Sell |
40,565
-1,328
| -3% | -$179K | 0.75% | 24 |
|
|
2017
Q4 | $5.85M | Sell |
41,893
-22,548
| -35% | -$3.14M | 0.79% | 25 |
|
|
2017
Q3 | $8.38M | Buy |
64,441
+14,925
| +30% | +$1.98M | 1.09% | 17 |
|
|
2017
Q2 | $6.55M | Buy |
49,516
+6,983
| +16% | +$891K | 0.96% | 19 |
|
|
2017
Q1 | $5.3M | Buy |
42,533
+2,562
| +6% | +$306K | 0.77% | 24 |
|
|
2016
Q4 | $4.61M | Buy |
+39,971
| New | +$4.62M | 0.75% | 24 |
|
Other funds holding JNJ
Clearstead Advisors's JNJ Position: Q2 2026 in Review
Clearstead Advisors reduced its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, selling an estimated $6.52M and leaving 234,177 shares worth $59.5M. The position accounts for 0.56% of the portfolio, ranked #41.
Clearstead Advisors first reported a position in JNJ in Q4 2016 and has held it in 39 quarters since. The position peaked at $64.1M in Q1 2026. 3,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Clearstead Advisors held 234,177 shares of Johnson & Johnson worth $59.5M as of Q2 2026.
- Clearstead Advisors sold 27,959 Johnson & Johnson shares in Q2 2026, an estimated $6.52M.
- Johnson & Johnson made up 0.56% of Clearstead Advisors's portfolio in Q2 2026, its #41 holding.
- Clearstead Advisors first reported a position in Johnson & Johnson in Q4 2016 and has held it in 39 quarters since.
- Clearstead Advisors's Johnson & Johnson position peaked at $64.1M in Q1 2026.
- 3,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.